Skip to content

Inspection prep notes · Sterility and contamination control

Aseptic technique and interventions

Also called: aseptic technique, aseptic practice, intervention

FDA looks less at whether aseptic procedures exist than at how operators actually moved during interventions. The findings below are quoted from warning letters and FDA 483s.

What inspectors cited

1Operators reached over open containers and blocked first air

Operators repeatedly broke first air by reaching their arms, torsos, and heads over open sterile tubes, (b)(4) , and open (b)(4) during (b)(4) interventions.

FDA Warning Letter · Hanlim Pharm Co., Ltd. · 2026-10-13 · View document

Operators block first air during the addition of stoppers.

FDA 483 · Jiangsu Hansoh Pharmaceutical Group Co Ltd. · 2026-10-22 · View document

2Operators put their upper body into the ISO 5 zone or RABS

During this study an operator (b)(4) the large (b)(4) and placed their upper torso inside the ISO 5 classified area.

FDA Warning Letter · Jubilant HollisterStier General Partnership · 2026-06-23

An operator was seen having to lean his upper body inside the RABS unit to retrieve and return forceps

FDA 483 · Jiangsu Hansoh Pharmaceutical Group Co Ltd. · 2026-10-22 · View document

3Operators moved quickly in or next to the critical area

Moved quickly in a critical area or in an area immediately adjacent to a critical area such that unidirectional airflow is likely to be disrupted.

FDA Warning Letter · SCA Pharmaceuticals, LLC · 2026-10-13 · View document

Specifically, On 06/02/2026, during aseptic production operations, an operator was observed moving quickly within ISO 5 LAFH [redacted] while performing aseptic manipulations.

FDA 483 · Lt Col Luke Weather Jr Veterans Affairs Medical Center · 2026-07-23 · View document

4Operators did not sanitize gloves or used gloved hands instead of sterile tools

The operator also used gloved hands instead of sterile tools to remove vials.

FDA Warning Letter · Jubilant HollisterStier General Partnership · 2026-06-23

The operator was observed to not perform frequent glove (hand) sanitization.

FDA 483 · Catalent Maryland, Inc. · 2026-10-30

5Interventions were not documented

Operators repeatedly used (b)(4) directly above and in contact with open bottles and critical surfaces during undocumented interventions without rejecting the exposed containers.

FDA Warning Letter · Rohto Pharmaceutical Co., Ltd. · 2026-10-20 · View document

Batch records do not contain documentation of all interventions performed in the Grade Aor the length of time taken to perform each intervention.

FDA 483 · Apotek Production & Laboratorier AB · 2026-10-22 · View document

Questions to check against your procedures

  1. Do operators' arms, upper bodies, and heads stay clear of open containers and product-contact surfaces during interventions?
  2. Are the speed and reach of operator movements in the filling area defined and checked, for example by video?
  3. Were interventions that require reaching or leaning into the RABS evaluated in smoke studies?
  4. Are glove sanitization timing and sterile tool use actually followed during work?
  5. Is every intervention on the filling line recorded in the batch record?
  6. Are the actions after an unplanned intervention or contact with open containers defined and followed?

Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.

Weekly Newsletter

New GMP inspection findings, every Monday

Every Monday we email the week's new inspection records from the FDA, EMA, Health Canada and MFDS, with a short summary of the week's regulatory news. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.